- Home
- FULC vs MEGI Comparison
FULC vs MEGI Comparison
Compare FULC & MEGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FULC | MEGI |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 718.4M | 783.3M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FULC | MEGI |
|---|---|---|
| Price | $7.50 | $15.02 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $16.38 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 205.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.32 | $11.40 |
| 52 Week High | $15.74 | $15.89 |
Technical Indicators
Market Signals| Indicator | FULC | MEGI |
|---|---|---|
| Relative Strength Index (RSI) | 32.44 | 47.17 |
| Support Level | $7.40 | $14.09 |
| Resistance Level | $7.64 | $15.05 |
| Average True Range (ATR) | 0.64 | 0.25 |
| MACD | -0.10 | -0.12 |
| Stochastic Oscillator | 1.00 | 25.19 |
Price Performance
Historical ComparisonAbout FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
About MEGI MainStay CBRE Global Infrastructure Megatrends Term Fund
NYLI CBRE Global Infrastructure Megatrends Term Fund is a non-diversified, closed-end management investment company. The Fund's investment objective is to seek a high level of total return with an emphasis on current income. It is focused on the investment megatrends of decarbonization, digital transformation and asset modernization, which are reshaping the demand for infrastructure assets and driving income and growth potential.